Biocept Inc (NASDAQ: BIOC) is having a relatively strong start to the trading session this morning, and for good reason. The company announced that it has been issued several patents in key territories, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about the patent news, what we’re seeing from BIOC, and what we’ll be watching for ahead.
BIOC Gains On Patent News
As mentioned above, Biocept is having a relatively strong start to the trading session this morning after announcing that it has been issued multiple new patents. In a press release issued early this morning, the company announced that it has been issued new patents in Europe, Japan, and Hong Kong. These patents surround the company’s core Target Selector liquid biopsy technology.
In the release, BIOC announced the names of the patents. In Japan, the patent is no. 6234817 titled “METHODS AND REAGENTS FOR SIGNAL AMPLIFICATION.” In Europe, patent no. 2995953 is titled “DEVICES AND METHODS OF CELL CAPTURE AND ANALYSIS.” Finally, the Hong Kong patent no. HK1191043 is titled “CELL SEPARATION USING MICROCHANNEL HAVING PATTERNED POSTS.” In a statement, Michael Nall, President and CEO at BIOC, had the following to offer:
Expanding Biocept’s patent protection around the world is an important component of our strategy and these newly issued patents strengthen the opportunity to develop business in major markets outside the U.S. We now have 25 issued patents for our core technologies and we intend to continue to broaden and leverage our intellectual property position throughout the year.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!